IP Library › Granted Patent US 12,263,869
Granted Patent B2
US 12,263,869 · App. 17/725,297 · Granted Apr 1, 2025

Medical emergency detection in-vehicle caretaker

Inventors: Akila C. Ganlath (Mountain View, CA); Rohit Gupta (Mountain View, CA); Paul Li (Mountain View, CA); Ziran Wang (Mountain View, CA); Kyungtae Han (Mountain View, CA); Nejib Ammar (Mountain View, CA); Satoshi Nagashima (Mountain View, CA)
B60W60/0016B60W40/08B60W60/005G16H40/67B60W2040/0818B60W2540/221B60W2540/229B60W2556/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,263,869
App. No.
17/725,297
Granted
Apr 1, 2025
Kind
B2
Abstract

The disclosure includes embodiments for a medic system to respond to a medical condition of a vehicle occupant. A method according to some embodiments is executed by a processor. The method also includes determining, by the processor, that a driver of an ego vehicle is experiencing a debilitating medical condition. The method also includes overriding a protocol to decrease an autonomy level of the ego vehicle responsive to inattentiveness of the driver to a driving interface of the ego vehicle so that the driver can be inattentive to the driving interface and the autonomy level is not decreased. The method also includes modifying an operation of an autonomous driving system of the ego vehicle to increase the autonomy level of the ego vehicle to decrease a driving responsibility of the driver responsive to the debilitating medical condition.

Claims (31)

1. A method executed by a processor, the method comprising:

determining, by the processor, that a driver of an ego vehicle is experiencing a debilitating medical condition;

overriding a protocol to decrease an autonomy level of the ego vehicle responsive to inattentiveness of the driver to a driving interface of the ego vehicle so that the driver can be inattentive to the driving interface and the autonomy level is not decreased; and

modifying an operation of an autonomous driving system of the ego vehicle to increase the autonomy level of the ego vehicle to decrease a driving responsibility of the driver responsive to the debilitating medical condition.

2. The method of claim 1 , wherein inattentiveness includes a level of attention to the driving interface that fails to satisfy a threshold.

3. The method of claim 1 , wherein overriding the protocol enables the driver to be inattentive to the driving interface and the autonomy level of the ego vehicle is not decreased.

4. The method of claim 1 , wherein increasing the autonomy level of the ego vehicle includes maximizing the autonomy level of the ego vehicle.

5. The method of claim 1 , further comprising identifying a remote driver of the ego vehicle, disabling the driving interface of the ego vehicle, and enabling the remote driver to control a driving operation of the ego vehicle from a remote location.

6. The method of claim 1 , further comprising disabling the driving interface of the ego vehicle and causing the autonomous driving system of the ego vehicle to drive the ego vehicle to a safe location.

7. The method of claim 1 , further comprising causing the autonomous driving system of the ego vehicle to drive the ego vehicle to an original destination.

8. The method of claim 1 , further comprising initiating a telehealth appointment with a medical service provider.

9. The method of claim 1 , further comprising identifying a remote medical service provider and causing the ego vehicle to be driven to an intercept location to meet the remote medical service provider.

10. The method of claim 9 , further comprising identifying a remote driver of the ego vehicle, disabling the driving interface of the ego vehicle, and enabling the remote driver to control the operation of the ego vehicle from a remote location and drive the ego vehicle to the intercept location.

11. The method of claim 9 , further comprising disabling the driving interface of the ego vehicle and causing the autonomous driving system of the ego vehicle to drive the ego vehicle to the intercept location.

12. The method of claim 9 , wherein the remote medical service provider is an ambulatory service provider.

13. The method of claim 9 , wherein the intercept location is a geographic location on a roadway that is along an intercept course driven by the ego vehicle and the remote medical service provider.

14. The method of claim 1 , wherein at least one step of the method is executed by a vehicular micro cloud.

15. The method of claim 1 , wherein at least one step of the method is executed by a processor-based computing device selected from a group including: an edge server; a cloud server; and a roadside unit.

16. The method of claim 1 , wherein a first degree of increase in the autonomy of the ego vehicle responsive to the debilitating medical condition is inversely proportional to a second degree of decrease in a driving ability of the driver based on the debilitating medical condition.

17. The method of claim 1 , further comprising determining how soon the debilitating medical condition will affect the driver.

18. The method of claim 1 , further comprising receiving feedback from the driver about one or more of whether they believe they are experiencing the debilitating medical condition and an immanency of the debilitating medical condition to affect their driving ability.

19. A system comprising:

a non-transitory memory;

and a processor communicatively coupled to the non-transitory memory, wherein the non-transitory memory stores computer readable code that is operable, when executed by the processor, to cause the processor to execute steps including:

determining that a driver of an ego vehicle is experiencing a debilitating medical condition;

overriding a protocol to decrease an autonomy level of the ego vehicle responsive to inattentiveness of the driver to a driving interface of the ego vehicle so that the driver can be inattentive to the driving interface and the autonomy level is not decreased; and

modifying an operation of an autonomous driving system of the ego vehicle to increase the autonomy level of the ego vehicle to decrease a driving responsibility of the driver responsive to the debilitating medical condition.

20. A computer program product including computer code stored on a non-transitory memory that is operable, when executed by a processor, to cause the processor to execute operations including:

determining that a driver of an ego vehicle is experiencing a debilitating medical condition;

overriding a protocol to decrease an autonomy level of the ego vehicle responsive to inattentiveness of the driver to a driving interface of the ego vehicle so that the driver can be inattentive to the driving interface and the autonomy level is not decreased; and

modifying an operation of an autonomous driving system of the ego vehicle to increase the autonomy level of the ego vehicle to decrease a driving responsibility of the driver responsive to the debilitating medical condition.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2025
From: TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC.
To: TOYOTA JIDOSHA KABUSHIKI KAISHA
Reel/Frame 071338/0482 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2022
From: AMMAR, NEJIB; GANLATH, AKILA C.; GUPTA, ROHIT; HAN, KYUNGTAE; LI, PAUL; NAGASHIMA, SATOSHI; WANG, ZIRAN
To: TOYOTA JIDOSHA KABUSHIKI KAISHA; TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC.
Reel/Frame 059735/0727 →
Continuity (1)
Related Publication 20230339508A1 · Oct 26, 2023
References Cited (30)
US 8085139B2 · Kanevsky et al. · 2011 [cited by applicant]
US 9149236B2 · Chun · 2015 [cited by examiner]
US 9157752B1 · Fernandez Garcia · 2015 [cited by examiner]
US 10395332B1 · Konrardy et al. · 2019 [cited by applicant]
US 10535341B2 · Penilla et al. · 2020 [cited by applicant]
US 11556175B2 · Farooq · 2023 [cited by examiner]
US 11814053B2 · Grentz · 2023 [cited by examiner]
US 11822327B2 · Magzimof · 2023 [cited by examiner]
US 11897513B2 · Kuranuki · 2024 [cited by examiner]
US 20040133082A1 · Abraham-Fuchs et al. · 2004 [cited by applicant]
US 20140221781A1 · Schrauf et al. · 2014 [cited by applicant]
US 20170364069A1 · Colella · 2017 [cited by examiner]
US 20190332902A1 · Gallagher et al. · 2019 [cited by applicant]
US 20200216078A1 · Katz · 2020 [cited by applicant]
US 20200401892A1 · Redding et al. · 2020 [cited by applicant]
US 20210146957A1 · Kim · 2021 [cited by examiner]
US 20210334645A1 · Pardeshi et al. · 2021 [cited by applicant]
US 20230282114A1 · Kumar · 2023 [cited by examiner]
US 20230339492A1 · Hoh · 2023 [cited by examiner]
US 20240184287A1 · Roberson · 2024 [cited by examiner]
CN 205302556U · 2016 [cited by applicant]
CN 108113657A · 2019 [cited by applicant]
CN 110426215A · 2019 [cited by applicant]
CN 109552289B · 2020 [cited by applicant]
KR 20180108033A · 2018 [cited by applicant]
WO 2020141485A1 · 2020 [cited by applicant]
WO 2021046172A1 · 2021 [cited by applicant]
“Connected Platform,” retrieved from Internet at https://www.toyotaconnected.co.jp/en/service/connectedplatform.html, 6 pages. [cited by applicant]
“Teammate Advanced Drive Backgrounder,” retrieved from Internet at https://pressroom.toyota.com/teammate-advanced-drive-backgrounder/, 6 pages, Jun. 3, 2021. [cited by applicant]
“Toyota's Discerning Approach to Car-making and Challenges for the Future,” retrieved from Internet at https://www.youtube.com/watch?v=1SdRWBwDMrA, Video, Aug. 25, 2021. [cited by applicant]